Standard InChI: InChI=1S/C21H26F2N4O3S/c22-14-5-6-18(23)17(7-14)21-19(24)8-15(12-30-21)26-10-13-9-25-27(20(13)11-26)31(28,29)16-3-1-2-4-16/h5-7,9,15-16,19,21H,1-4,8,10-12,24H2/t15-,19+,21-/m1/s1
1. (2013) Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes,
2.Chen P, Feng D, Qian X, Apgar J, Wilkening R, Kuethe JT, Gao YD, Scapin G, Cox J, Doss G, Eiermann G, He H, Li X, Lyons KA, Metzger J, Petrov A, Wu JK, Xu S, Weber AE, Yan Y, Roy RS, Biftu T.. (2015) Structure-activity-relationship of amide and sulfonamide analogs of omarigliptin., 25 (24):[PMID:26546218][10.1016/j.bmcl.2015.10.070]
3.Kumar S, Mittal A, Mittal A.. (2021) A review upon medicinal perspective and designing rationale of DPP-4 inhibitors., 46 [PMID:34428715][10.1016/j.bmc.2021.116354]